ATE296827T1 - Heteropolycyclische inhibitoren - Google Patents

Heteropolycyclische inhibitoren

Info

Publication number
ATE296827T1
ATE296827T1 AT01955500T AT01955500T ATE296827T1 AT E296827 T1 ATE296827 T1 AT E296827T1 AT 01955500 T AT01955500 T AT 01955500T AT 01955500 T AT01955500 T AT 01955500T AT E296827 T1 ATE296827 T1 AT E296827T1
Authority
AT
Austria
Prior art keywords
heteropolycyclic
inhibitors
administering
compound
formula
Prior art date
Application number
AT01955500T
Other languages
English (en)
Inventor
Zaihui Zhang
Xinyao Du
Greg Chopiuk
Serguei Sviridov
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE296827T1 publication Critical patent/ATE296827T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01955500T 2000-07-06 2001-07-06 Heteropolycyclische inhibitoren ATE296827T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61103800A 2000-07-06 2000-07-06
PCT/IB2001/001519 WO2002002562A2 (en) 2000-07-06 2001-07-06 Heteropolycyclic inhibitors

Publications (1)

Publication Number Publication Date
ATE296827T1 true ATE296827T1 (de) 2005-06-15

Family

ID=24447360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01955500T ATE296827T1 (de) 2000-07-06 2001-07-06 Heteropolycyclische inhibitoren

Country Status (8)

Country Link
US (2) US6514972B2 (de)
EP (1) EP1296985B1 (de)
AT (1) ATE296827T1 (de)
AU (1) AU2001277659A1 (de)
CA (1) CA2414885A1 (de)
DE (1) DE60111228T2 (de)
ES (1) ES2243527T3 (de)
WO (1) WO2002002562A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514972B2 (en) * 2000-07-06 2003-02-04 Kinetek Pharmaceuticals, Inc. Heteropolycyclic inhibitors of protein kinases
US8715708B2 (en) * 2005-08-31 2014-05-06 University Of Maryland Cyclic acetal biomaterials
EP1798232A1 (de) * 2005-12-08 2007-06-20 Hybrigenics S.A. Cysteine Proteasehemmer, deren pharmazeutische Zusammensetzungen und therapeutische Anwendungen
AU2006322958B2 (en) * 2005-12-08 2012-06-07 Hybrigenics Sa Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US7462615B2 (en) * 2005-12-08 2008-12-09 Hybrigenics Sa Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
NZ576606A (en) * 2006-10-30 2012-04-27 Hybrigenics Sa Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US7875613B2 (en) * 2006-10-30 2011-01-25 Hybrigenics Sa Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
EP1918292A1 (de) * 2006-10-30 2008-05-07 Hybrigenics S.A. Tetrazyklische Inhibitoren für Cysteinproteasen, pharmazeutische Zubereitungen und therapeutische Anwendungen
WO2012006104A2 (en) * 2010-06-28 2012-01-12 Academia Sinica, Taiwan Compounds and methods for treating tuberculosis infection
CN103520165A (zh) * 2013-10-31 2014-01-22 华东理工大学 茚并三嗪类化合物作为依赖nad(p)h的醌氧化还原酶底物的用途
US10517871B2 (en) 2015-05-15 2019-12-31 Indiana University Research And Technology Corporation Survivin-targeting anti-tumor agents and uses thereof
CN105061360B (zh) * 2015-07-28 2018-06-19 首都师范大学 一种3,4-二氨基-1,2,5-噻二唑的提纯方法
JP2022511371A (ja) * 2018-09-28 2022-01-31 アキュセラ インコーポレイテッド Vap-1の阻害剤
US20220143033A1 (en) * 2020-11-10 2022-05-12 New Mexico Tech University Research Park Corporation Kp372-1-induced dna damage as a chemotherapeutic approach to treat cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4159375A (en) * 1978-08-24 1979-06-26 American Cyanamid Company 6- AND 7-Aryl-1,2,4-triazolo[4,3-b]-1,2,4-triazines
US4405619A (en) * 1981-09-02 1983-09-20 Diamond Shamrock Corporation Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines
GB8826237D0 (en) 1988-11-09 1988-12-14 Univ Belfast Fingerprint reagent
WO1995024190A2 (en) 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
AU2001240021A1 (en) * 2000-04-13 2001-10-30 Millennium Pharmaceuticals, Inc. Diazafluorenone il-8 receptor antagonists
US6514972B2 (en) * 2000-07-06 2003-02-04 Kinetek Pharmaceuticals, Inc. Heteropolycyclic inhibitors of protein kinases

Also Published As

Publication number Publication date
EP1296985B1 (de) 2005-06-01
DE60111228T2 (de) 2006-03-16
US20030144294A1 (en) 2003-07-31
EP1296985A2 (de) 2003-04-02
WO2002002562A2 (en) 2002-01-10
US6514972B2 (en) 2003-02-04
US7196083B2 (en) 2007-03-27
WO2002002562A3 (en) 2002-05-02
CA2414885A1 (en) 2002-01-10
ES2243527T3 (es) 2005-12-01
DE60111228D1 (de) 2005-07-07
US20020035251A1 (en) 2002-03-21
AU2001277659A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
DK1223980T3 (da) Anvendelse af CSF-1-inhibitorer
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
DE60111228D1 (de) Heteropolycyclische inhibitoren
ATE377004T1 (de) Proteinkinaseinhibitoren
ATE457025T1 (de) Kinaseinhibitoren
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
DE60335359D1 (de) Phthalazinonderivate
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
BG106585A (en) Kinase inhibitors as therapeutic agents
CY1107634T1 (el) Φαρμακευτικη συνθεση
EA200200769A1 (ru) Ингибиторы гиразы и их применение
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
DK1565471T3 (da) Quionolinylpyrazoler
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
SE0104248D0 (sv) Method of treatment
EA200101077A1 (ru) Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
GB9903403D0 (en) Substituted stilbene compounds with vascular damaging activity
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
SE0004827D0 (sv) Therapeutic compounds
MXPA03000337A (es) Inhibidores de trombina que comprenden un grupo aminoisoquinolina.
MXPA05003909A (es) Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer.
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
DE60108873D1 (de) Nicht-antibakterielle tetrazykline als anti-pilz medikamente
DK1011672T3 (da) Anvendelse af (E)-metanicotin derivater til frembringelse af analgetiske virkninger

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1296985

Country of ref document: EP

REN Ceased due to non-payment of the annual fee